BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 22, 2007
View Archived Issues
Preclinical and clinical studies on Rebif(R) new formulation
Read More
Recent patents disclose new agents for depression, anxiety, psychosis and sleep disorders
Read More
Novel agents for treating endocrine-related disorders disclosed in recent patent literature
Read More
New therapeutic agents for respiratory and allergic disorders disclosed in recent patents
Read More
Novartis invests in Adenosine Therapeutics
Read More
Health Canada approves once-daily tramadol
Read More
Merck Serono and Ambrx collaborate on growth hormone products
Read More
OSI Pharmaceuticals begins phase I trials of OSI-906 for tumors
Read More
Recent Janssen and Pfizer patents describe novel analgesic agents
Read More
Rylomine significantly reduces postsurgical orthopedic pain
Read More
Interim findings for AVN-944 in hematologic malignancies
Read More
Kaken and Sunstar sign agreement for bFGF dental product development
Read More
NOP receptor antagonist improves parkinsonian-related motor dysfunction
Read More
New preclinical data on short-acting sedative CNS-7056
Read More
Liraglutide provides better glucose control than insulin glargine in phase III study
Read More
Phosphagenics delivery technology shows promise in dermatological fields
Read More
EULAR 2007: Studies of certolizumab pegol in rheumatoid arthritis
Read More
ARRY-797 meets endpoints in phase I study
Read More
ZymoGenetics and Bayer collaborate in global development of rThrombin
Read More
FDA agrees on SPA for OxyADF phase III trial
Read More
Bayer Schering Pharma to license imaging agent from Avid
Read More
DeveloGen grants worldwide exclusive license to Teva for protein kinase B
Read More
Resverlogix and Sun Health Research Institute collaborate for treatment of AD
Read More
Genzyme seeks FDA approval of Synvisc-One
Read More
Inulin polysulfate in vitro studies indicate potential to prevent osteoarthritis progression
Read More
Approvable letter for Risperdal sNDAs
Read More